Central serous chorioretinopathy in giant cell arteritis. uri icon

Overview

abstract

  • A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD > OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.

publication date

  • January 1, 2006

Research

keywords

  • Choroid Diseases
  • Giant Cell Arteritis
  • Retinal Diseases

Identity

Scopus Document Identifier

  • 33646937989

Digital Object Identifier (DOI)

  • 10.1080/08820530500511396

PubMed ID

  • 16517445

Additional Document Info

volume

  • 21

issue

  • 1